company

NORMEDISIN AS

9731 KARASJOK

Return on Equity
16,57 %
Current Ratio
1,24
Debt-to-Equity Ratio
0
Key figures (NOK)2022
Revenue1 706 000
Net Income463 000
Total Assets3 104 000
Total Equity2 794 000
Income (NOK)2022
Revenue1 706 000
Expenditure854 000
Operating Profit852 000
Financial Income1 000
Financial Costs202 000
Financial Balance−201 000
Earnings Before Tax650 000
Tax187 000
Net Income463 000
Balance (NOK)2022
Total Fixed Assets2 730 000
Total Current Assets374 000
Total Assets3 104 000
Total Retained Equity2 694 000
Total Equity2 794 000
Total Long-Term Debt9 000
Total Current Debt301 000
Total Equity and Debt3 104 000
Cash flow (NOK)2022
Sales Income1 705 000
Other Income2 000
Revenue1 706 000
Cost of Goods Sold0
Salary Costs294 000
Depreciation19 000
Impairment0
Expenditure854 000
Operating Profit852 000
Financial Income1 000
Financial Costs202 000
Financial Balance−201 000
Dividends0
Net Income463 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets0
Real Eastate174 000
Machinery and Plant Facilities35 000
Fixtures32 000
Total Tangible Assets241 000
Total Fiancial Fixed Assets2 489 000
Total Fixed Assets2 730 000
Stock0
Total Investments0
Cash, Bank290 000
Total Current Assets374 000
Total Assets3 104 000
Total Equity2 794 000
Short-Term Group Debt0
Total Long-Term Debt9 000
Creditors−20 000
Unpaid Taxes76 000
Dividends0
Other Current Debt65 000
Total Current Debt301 000
Total Equity and Debt3 104 000
Financial indicators2022
Return on Equity16,57 %
Debt-to-Equity Ratio0
Operating Profit Margin49,94 %
Current Ratio1,24
Quick Ratio1,24
Equity Ratio0,9
Gross Profit Margin100 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English